TARA Stock Price
Protara Therapeutics, Inc.
TARA stock price is $2.48 (-5.34% on the day), giving Protara Therapeutics, Inc. a market cap of $146.56M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
TARA Stock Overview
- Price
- $2.48
- Previous close
- $2.62
- Open
- $2.60
- Market cap
- $146.56M
- P/E ratio
- -2.6
- 52-week range
- $2.51 - $7.82
- 1-year price target
- $26.57
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 35
About Protara Therapeutics, Inc.
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TARA | $2.48 | -5.3% | 701.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protara Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW